384 studies found for:    diabetes and type 1 and open and active | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
diabetes and type 1 and open and active | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.
Condition: Type 1 Diabetes
Interventions: Behavioral: Intensive Physical activity;   Behavioral: Control- regular physical activity
2 Recruiting Diabeloop WP6.2 : Crossover Evaluation of Glycemic Control
Conditions: Closed Loop;   Diabetes Mellitus, Type 1
Interventions: Device: Diabeloop System;   Device: Continuous Glucose Monitoring;   Device: Accelerometer and heart rate monitor;   Dietary Supplement: Meals
3 Recruiting A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin glargine (U300) HOE901;   Drug: Insulin glargine HOE901;   Drug: Insulin glulisine HMR1964;   Drug: Insulin aspart;   Drug: Insulin lispro
4 Recruiting Evaluation of Automated Insulin Pump Settings Using the MD-Logic Advise4U
Condition: Type 1 Diabetes
Interventions: Device: MD-Logic Pump Advisor;   Other: Control Group
5 Not yet recruiting Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 6-day intervention with sensor-augmented pump therapy;   Other: 6-day intervention with single-hormone closed-loop strategy;   Other: 6-day intervention with dual-hormone closed-loop strategy;   Drug: Insulin;   Drug: Glucagon;   Device: Continuous Glucose Monitoring System Enlite sensor®, Medtronic;   Device: Insulin pump MiniMed® Paradigm® Veo™, Medtronic
6 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 5-day intervention with single-hormone closed-loop strategy;   Other: 5-day intervention with sensor-augmented pump therapy;   Other: 5-day intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
7 Recruiting Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: Sitagliptin;   Drug: Exercise
8 Not yet recruiting An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Exenatide;   Drug: Albiglutide
9 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 2 Weeks in Adolescents and Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 15-week intervention with sensor-augmented pump;   Other: 15-week intervention with single-hormone closed-loop;   Other: 15-week intervention with dual-hormone closed-loop;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
10 Not yet recruiting Closed-loop Control of Glucose Levels (Artificial Pancreas) for 2 Weeks in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Other: 2-week intervention with sensor-augmented pump therapy;   Other: 2-week intervention with single-hormone closed-loop strategy;   Other: 2-week intervention with dual-hormone closed-loop strategy;   Device: Insulin pump;   Device: Continuous glucose monitoring system;   Drug: Insulin;   Drug: Glucagon
11 Recruiting Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: MD- Logic Closed Loop System;   Device: sensor augmented pump therapy
12 Recruiting At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation
Condition: Type 1 Diabetes Mellitus
Interventions: Device: CGM and Insulin Pump;   Device: Closed-Loop Control System
13 Recruiting Home Testing of Day and Night Closed Loop With Pump Suspend Feature
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Other: FlorenceM;   Other: Medtronic insulin pump 640G
14 Unknown  Closing the Loop in Young Children With Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: Overnight closed-loop insulin delivery
15 Recruiting Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: Patient's insulin pump;   Drug: Insulin;   Device: Dexcom G4 Platinum glucose sensor;   Other: Single-hormone closed-loop
16 Unknown  A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Drug: HM11260C;   Drug: Placebo;   Drug: Victoza
17 Recruiting Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
Condition: Diabetes Mellitus, Type I
Interventions: Device: Dexcom G4 Platinum CGM system;   Device: Dexcom G4 Platinum CGM system with Share
18 Not yet recruiting Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients
Condition: Type I Diabetes
Interventions: Biological: Wockhardt's Insulin Analogue (Recomb);   Biological: Lantus®
19 Recruiting Physical Activity and Glycemic Control in Adolescents
Condition: Type 1 Diabetes
Interventions: Behavioral: Reinforcement for meeting targeted physical activity goals;   Other: Standard of Care
20 Recruiting A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin, Onglyza;   Drug: Dapagliflozin, Farxiga;   Drug: Glargine insulin;   Drug: Metformin XR

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years